Skip to main content

CORRECTION article

Front. Immunol., 06 November 2023
Sec. Cancer Immunity and Immunotherapy
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1328927

Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges

This article is a correction to:

  1. Alveolar macrophages in lung cancer: opportunities and challenges

    1. Read original article
Cheng-Yen ChangCheng-Yen Chang1Dominique ArmstrongDominique Armstrong1David B. Corry,,,David B. Corry1,2,3,4Farrah Kheradmand,,,*Farrah Kheradmand1,2,3,4*
  • 1Department of Medicine, Baylor College of Medicine, Houston, TX, United States
  • 2Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States
  • 3Biology of Inflammation Center, Baylor College of Medicine, Houston, TX, United States
  • 4Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, TX, United States

A Corrigendum on:
Alveolar macrophages in lung cancer: opportunities and challenges

by Chang C-Y, Armstrong D, Corry DB and Kheradmand F (2023) Front. Immunol. 14:1268939. doi: 10.3389/fimmu.2023.1268939

In the published article, there was an error in the article title. Instead of “Alveolar Macrophages in Lung Cancer: Opportunities Challenges”, it should be “Alveolar Macrophages in Lung Cancer: Opportunities and Challenges”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: tissue-resident alveolar macrophages, smoking, lung cancer, immune checkpoint inhibitors, tumor-associated macrophages, tumor microenvironment

Citation: Chang C-Y, Armstrong D, Corry DB and Kheradmand F (2023) Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges. Front. Immunol. 14:1328927. doi: 10.3389/fimmu.2023.1328927

Received: 27 October 2023; Accepted: 30 October 2023;
Published: 06 November 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Chang, Armstrong, Corry and Kheradmand. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Farrah Kheradmand, ZmFycmFoa0BiY20uZWR1

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.